IBDEI1SJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31989,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,31990,0)
 ;;=A60.01^^190^1945^27
 ;;^UTILITY(U,$J,358.3,31990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31990,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,31990,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,31990,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,31991,0)
 ;;=B00.1^^190^1945^28
 ;;^UTILITY(U,$J,358.3,31991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31991,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,31991,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,31991,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,31992,0)
 ;;=B97.89^^190^1945^81
 ;;^UTILITY(U,$J,358.3,31992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31992,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,31992,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,31992,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,31993,0)
 ;;=B97.10^^190^1945^20
 ;;^UTILITY(U,$J,358.3,31993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31993,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,31993,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,31993,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,31994,0)
 ;;=B34.9^^190^1945^82
 ;;^UTILITY(U,$J,358.3,31994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31994,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,31994,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,31994,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,31995,0)
 ;;=A69.20^^190^1945^45
 ;;^UTILITY(U,$J,358.3,31995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31995,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,31995,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,31995,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,31996,0)
 ;;=A69.22^^190^1945^47
 ;;^UTILITY(U,$J,358.3,31996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31996,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,31996,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,31996,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,31997,0)
 ;;=A69.21^^190^1945^46
 ;;^UTILITY(U,$J,358.3,31997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31997,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,31997,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,31997,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,31998,0)
 ;;=A69.29^^190^1945^17
 ;;^UTILITY(U,$J,358.3,31998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31998,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,31998,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,31998,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,31999,0)
 ;;=A69.23^^190^1945^5
 ;;^UTILITY(U,$J,358.3,31999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31999,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,31999,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,31999,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,32000,0)
 ;;=A51.0^^190^1945^24
 ;;^UTILITY(U,$J,358.3,32000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32000,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,32000,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,32000,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,32001,0)
 ;;=A52.3^^190^1945^49
 ;;^UTILITY(U,$J,358.3,32001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32001,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,32001,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,32001,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,32002,0)
 ;;=A52.10^^190^1945^48
 ;;^UTILITY(U,$J,358.3,32002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32002,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,32002,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,32002,2)
 ;;=^5000291
